Skip to main navigation

Skip to main content
Skip to footer

Scholar Rock - Utility Menu

Careers
Contact Us

Main navigation

Our Company
Our Science
Our Pipeline
Patients & Families
Investors & Media

Breadcrumb

Home / Investors & Media / Investors & Media / Press releases

Press releases

Explore Investors & Media

Investor Overview
Press Releases
- Archived Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
- SEC Filings
Stock Information
Investor FAQs
Contact IR

Year

September 9, 2020

Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

Read This Press Release

September 2, 2020

Scholar Rock to Present at Upcoming Healthcare Conferences

Read This Press Release

August 27, 2020

Scholar Rock Announces Issuance of U.S. Patent Providing Composition of Matter Protection for SRK-015

Read This Press Release

August 13, 2020

Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of Spinal Muscular Atrophy

Read This Press Release

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Archived Press Releases

RSS Feeds
Search

Footer

SCHOLAR ROCK
620 Memorial Dr 2nd Floor
Cambridge, MA 02139

MOVING EARLY 2021 TO
301 Binney Street, 3rd Floor
Cambridge, MA 02142

Phone: 857.259.3860
info@scholarrock.com

LinkedIn Twitter

Scholar Rock - Main navigation

Our Company
Our Science
Our Pipeline
Patients & Families
Investors & Media

Community Guidelines
Expanded Access Policy

Terms of Use
Privacy Policy

Scholar Rock, Inc. © 2020 All Rights Reserved

Scholar Rock - Main navigation

Our Company
Our Science
Our Pipeline
Patients & Families
Investors & Media

Scholar Rock - Utility Menu

Careers
Contact Us